We work in the most important field there is – health. It’s absolutely fundamental in order to experience and enjoy all aspects of life. With this belief at the core, the company was founded by senior executives in 2016. Since then, we have grown rapidly and during 2022 we passed 40 million EUR in sales. We operate in Northern Europe with offices in Stockholm, Helsinki and Munich and focus on five therapy areas: women’s health, urology, dermatology, allergy and general OTC. Currently we have over 30 products in our portfolio – a combination of our own as well as in-licensed pharmaceuticals from international companies like Endoceutics, Perrigo, Menarini and Dr Pfleger.
In addition to organic growth, we are always on the lookout to make new acquisitions. Companies and products that make valuable contributions to our four therapy areas and that instantly boosts our market share and delivers on our ambitious growth strategy. We focus on pharmaceuticals but also consider medical devices and food supplements if there is a good fit with the overall portfolio. New agreements are already established and we will launch several new products in the coming years.
But this is just the beginning – our main goal is to become the market leader in selected therapeutic areas.
Every day our products help to improve life for both young and old – but we always strive to do more. And women’s health is especially close to our hearts. Therefore the decision to support Cancerfonden and their campaign “Rosa Bandet” was easy to make. Every day 20 women in Sweden are diagnosed with breast cancer. It’s the most common form of cancer in women. Screening, diagnosis and treatment are continuously improving – but there are always more to be done. Because if it’s detected at an early stage it increases the chance of being cured, and in the end, save lives.